GWP
GILD icon

Gateway Wealth Partners’s Gilead Sciences GILD Stock Holding History

Gateway Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.44M Buy
10,298
+6,225
+153% +$872K 0.06% 311
2025
Q4 		$500K Buy
4,073
+19
+0.5% +$2.31K 0.06% 276
2025
Q3 		$450K Sell
4,054
-155
-4% -$17.6K 0.06% 257
2025
Q2 		$467K Buy
4,209
+288
+7% +$30.6K 0.09% 206
2025
Q1 		$439K Buy
3,921
+271
+7% +$28K 0.1% 199
2024
Q4 		$337K Buy
3,650
+71
+2% +$6.39K 0.09% 215
2024
Q3 		$300K Sell
3,579
-499
-12% -$38.1K 0.08% 212
2024
Q2 		$280K Sell
4,078
-381
-9% -$25.4K 0.08% 212
2024
Q1 		$327K Buy
4,459
+1,233
+38% +$94.8K 0.12% 162
2023
Q4 		$261K Sell
3,226
-209
-6% -$16.3K 0.11% 171
2023
Q3 		$257K Buy
3,435
+399
+13% +$30.7K 0.05% 215
2023
Q2 		$234K Buy
+3,036
New +$242K 0.04% 213
2023
Q1 		– Sell
-2,476
Closed -$213K – 237
2022
Q4 		$213K Buy
+2,476
New +$196K 0.04% 185

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Gateway Wealth Partners's GILD Position: Q1 2026 in Review

Gateway Wealth Partners increased its Gilead Sciences (GILD) stake by 153% in Q1 2026, buying an estimated $872K and bringing the position to 10,298 shares worth $1.44M. The position accounts for 0.06% of the portfolio, ranked #311.

Gateway Wealth Partners first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Gateway Wealth Partners held 10,298 shares of Gilead Sciences worth $1.44M as of Q1 2026.
  • Gateway Wealth Partners bought 6,225 Gilead Sciences shares in Q1 2026, an estimated $872K.
  • Gilead Sciences made up 0.06% of Gateway Wealth Partners's portfolio in Q1 2026, its #311 holding.
  • Gateway Wealth Partners first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Gateway Wealth Partners's 13F filing for Q1 2026, filed 15 May 2026.